CAMBRIDGE, Mass. & DANBURY, Conn.--
Genzyme,
a Sanofi company (EURONEXT: SAN and NYSE: SNY), and the National
Organization for Rare Disorders (NORD) today announced the creation of a
fund to pay for standard diagnostic testing for people with mysterious,
undiagnosed medical conditions. The fund will help those who have
applied to the National Institutes of Health (NIH) Undiagnosed Diseases
Program, but who cannot afford the basic medical tests needed to make
them eligible to participate in the NIH program.
more...